Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, O'Donnell D, Knight BP, Clémenty N, Leclercq C, Amin A, Merkely BP, Birgersdotter-Green UM, Chan JYS, Biffi M, Knops RE, Engel G, Muñoz Carvajal I, Epstein LM, Sagi V, Johansen JB, Sterliński M, Steinwender C, Hounshell T, Abben R, Thompson AE, Wiggenhorn C, Willey S, Crozier I; Extravascular ICD Pivotal Study Investigators.
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.
Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.
Black-Maier E, Lewis RK, Rehorn M, Loungani R, Friedman DJ, Frazier-Mills C, Jackson KP, Atwater BD, Milano CA, Schroder JN, Pokorney SD, Piccini JP.
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1509-1518. doi: 10.1111/jce.14487. Epub 2020 Apr 29.
Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.
Kuck KH, Merkely B, Zahn R, Arentz T, Seidl K, Schlüter M, Tilz RR, Piorkowski C, Gellér L, Kleemann T, Hindricks G.
Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e007731. doi: 10.1161/CIRCEP.119.007731. Epub 2019 Nov 25.
The story of a lead.
Nisam S, Reddy S.
Europace. 2015 May;17(5):677-88. doi: 10.1093/europace/euu391. Epub 2015 Mar 8.
Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM.
Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):582-90. doi: 10.1161/CIRCOUTCOMES.113.000299. Epub 2013 Sep 3.
[Cardiac remodelling and function after cardiovascular implantable electronic devices implantation].
Stanek A, Lelakowski J, Matusik PT.
Pol Merkur Lekarski. 2019 Apr 29;46(274):187-189.
Early ICD lead failure in defibrillator systems with multiple leads via cephalic access.
Barbhaiya CR, Niazi O, Bostrom J, Patil S, Jankelson L, Bernstein S, Park D, Holmes D, Aizer A, Chinitz LA.
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1462-1469. doi: 10.1111/jce.14523. Epub 2020 May 16.
Implantable Cardioverter Defibrillator Lead Survival in Athletic Patients.
Link MS, Sullivan RM, Olshansky B, Cannom D, Berul CI, Hauser RG, Heidbuchel H, Jordaens L, Krahn AD, Morgan J, Patton KK, Saarel EV, Wilkoff BL, Li F, Dziura J, Brandt C, Barth C, Lampert R.
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009344. doi: 10.1161/CIRCEP.120.009344. Epub 2021 Mar 16.
Prevention of Sudden Cardiac Death: Focus on the Subcutaneous Implantable Cardioverter-Defibrillator.
Adduci C, Palano F, Silvetti G, Cosentino P, Francia P.
High Blood Press Cardiovasc Prev. 2020 Aug;27(4):291-297. doi: 10.1007/s40292-020-00394-x. Epub 2020 Jun 9.
Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.
Providência R, Kramer DB, Pimenta D, Babu GG, Hatfield LA, Ioannou A, Novak J, Hauser RG, Lambiase PD.
J Am Heart Assoc. 2015 Oct 30;4(11):e002418. doi: 10.1161/JAHA.115.002418.
